Jeevan Specility Hospital And Test Tube Baby Centre Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-05-2024
- Paid Up Capital ₹ 0.10 M
as on 23-05-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Net Worth 21.17%
(FY 2022)
- Total Assets -12.01%
(FY 2022)
About Jeevan Specility Hospital And Test Tube Baby Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Divya Chaudhary and Jayant Sharma serve as directors at the Company.
- CIN/LLPIN
U33110UP2009PTC038043
- Company No.
038043
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Aligarh, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jeevan Specility Hospital And Test Tube Baby Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divya Chaudhary  | Director | 21-Aug-2009 | Current |
| Jayant Sharma | Director | 21-Aug-2009 | Current |
Financial Performance and Corporate Structure Insights of Jeevan Specility Hospital And Test Tube Baby Centre.
Jeevan Specility Hospital And Test Tube Baby Centre Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 21.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jeevan Specility Hospital And Test Tube Baby Centre?
In 2021, Jeevan Specility Hospital And Test Tube Baby Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
2 years 6 months Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jeevan Specility Hospital And Test Tube Baby Centre?
Unlock and access historical data on people associated with Jeevan Specility Hospital And Test Tube Baby Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jeevan Specility Hospital And Test Tube Baby Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jeevan Specility Hospital And Test Tube Baby Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
